@revivethera.com
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
Icon
JPEG
About
Description
Revive Therapeutics Ltd. (CSE: RVV, USA: RVVTF) is a life sciences company specializing in the research and development of therapeutics for rare disorders and infectious diseases. With a focus on rare inflammatory diseases, Revive has built a robust cannabinoid pharmaceutical portfolio.
They have been granted FDA orphan drug status designation for their use of CBD in treating auto-immune hepatitis and ischemia and reperfusion injury from organ transplantation. Revive recently acquired Psilocin Pharma Corp., a subsidiary that is dedicated to advancing Psilocybin-based therapeutics for various diseases and disorders. This acquisition allows Revive to take advantage of several regulatory incentives awarded by the FDA, including Orphan Drug, Fast Track, Breakthrough Therapy, and Rare Pediatric Disease designations.
In addition, Revive is exploring the potential use of Bucillamine for infectious diseases, including COVID-19. With a strong commitment to innovation and patient care, Revive Therapeutics is at the forefront of developing groundbreaking treatments to improve the lives of those affected by rare disorders and infectious diseases. Visit their website to learn more about their cutting-edge research and advancements in the field of life sciences
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories